QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
📢Publication alert!
We are pleased to share that the NORDSTAR manuscript ” From mild-to-moderate to severe asthma: Risk factors and patient profiles from the NORDSTAR cohort” has been published in the American Journal of Respiratory and Critical Care Medicine.
Using Danish nationwide registry data from the NORDSTAR collaboration platform, the study included 99,748 adults with mild-to-moderate asthma who experienced their first asthma exacerbation between 1 July 2000 and 31 December 2018.
Patients were […]
Convini Stafetten
Yesterday, two teams of runner from Quantify Research challenged themselves at the annual Convini Stafetten: A 5x5km relay race.
The team covered a total of 50km and had lots of fun along the way! Here’s us before and after – can you tell which is which?
[…]
A new face at Quantify Research India
Meet Harrdik Kamra who recently joined our team as Junior Accountant.
Hardik brings more than five years of experience from the wellness, telecommunications, and IT industries.
His work has covered core finance operations including invoices, payroll, inventory, compliance, accounting systems, and Excel-based reporting.
We value people who combine strong technical foundations with a careful, dependable way of working, and Hardik brings exactly that mindset.
Away […]
Beyond the trial population
Randomized trials tell us what happened in the trial. But how far can those findings extend into routine care?
We are pleased to share a new paper in Epidemiology, first-authored by our colleague Jessica Young.
Using data from VALIDATE-SWEDEHEART and Swedish healthcare registries, the study extended trial inferences to two clinically relevant target populations:
🔹 The full trial-eligible population, regardless of trial enrolment
🔹 The broader treatment-candidate population, regardless of trial eligibility
The first […]
